Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Articles|February 10, 2010

Borderline personality disorder patient resources

Borderline Personality DisorderNational Institute of Mental Health

Borderline Personality DisorderMayo Clinic

Symptoms of Borderline Personality DisorderWebMD

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Trending on Psychiatric Times

The 5 Faces of Bipolar Depression: A Case-Based Reflection

Benzodiazepines in Older Adults: Alzheimer Risk, Memory, and Beers Criteria

Psychiatry on Trial: Are Psychiatrists Responsible for Their Patients’ Criminal Behavior?

Changes in Self-Awareness Following Traumatic Brain Injury: Assessment and Practical Treatment Considerations

Perimenopausal Depression May Signal a Hormonal Component: When to Consider HRT